218 related articles for article (PubMed ID: 27243216)
1. LPS/TLR4 Signaling Enhances TGF-β Response Through Downregulating BAMBI During Prostatic Hyperplasia.
He Y; Ou Z; Chen X; Zu X; Liu L; Li Y; Cao Z; Chen M; Chen Z; Chen H; Qi L; Wang L
Sci Rep; 2016 May; 6():27051. PubMed ID: 27243216
[TBL] [Abstract][Full Text] [Related]
2. Curcumin attenuates prostatic hyperplasia caused by inflammation
Liu Y; Wang Z; Gan Y; Chen X; Zhang B; Chen Z; Liu P; Li B; Ru F; He Y
Pharm Biol; 2021 Dec; 59(1):1026-1035. PubMed ID: 34357837
[TBL] [Abstract][Full Text] [Related]
3. Leptin promotes epithelial-mesenchymal transition in benign prostatic hyperplasia through downregulation of BAMBI.
Zhang B; Chen X; Xie C; Chen Z; Liu Y; Ru F; He Y
Exp Cell Res; 2020 Feb; 387(1):111754. PubMed ID: 31805276
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional repression of the transforming growth factor β (TGF-β) Pseudoreceptor BMP and activin membrane-bound inhibitor (BAMBI) by Nuclear Factor κB (NF-κB) p50 enhances TGF-β signaling in hepatic stellate cells.
Liu C; Chen X; Yang L; Kisseleva T; Brenner DA; Seki E
J Biol Chem; 2014 Mar; 289(10):7082-7091. PubMed ID: 24448807
[TBL] [Abstract][Full Text] [Related]
5. Statin pretreatment inhibits the lipopolysaccharide-induced epithelial-mesenchymal transition via the downregulation of toll-like receptor 4 and nuclear factor-κB in human biliary epithelial cells.
Kim Y; Lee EJ; Jang HK; Kim CH; Kim DG; Han JH; Park SM
J Gastroenterol Hepatol; 2016 Jun; 31(6):1220-8. PubMed ID: 26574150
[TBL] [Abstract][Full Text] [Related]
6. miR-1202 regulates BPH-1 cell proliferation, apoptosis, and epithelial-to-mesenchymal transition through targeting HMGCL.
Wang Z; Yin X; Yang P; Gong B; Liu H
Acta Biochim Biophys Sin (Shanghai); 2024 May; 56(5):675-687. PubMed ID: 38551020
[TBL] [Abstract][Full Text] [Related]
7. Targeting androgen receptor to suppress macrophage-induced EMT and benign prostatic hyperplasia (BPH) development.
Lu T; Lin WJ; Izumi K; Wang X; Xu D; Fang LY; Li L; Jiang Q; Jin J; Chang C
Mol Endocrinol; 2012 Oct; 26(10):1707-15. PubMed ID: 22915828
[TBL] [Abstract][Full Text] [Related]
8. MIR663AHG as a competitive endogenous RNA regulating TGF-β-induced epithelial proliferation and epithelial-mesenchymal transition in benign prostate hyperplasia.
Tong S; Mo M; Hu X; Wu L; Chen M; Zhao C
J Biochem Mol Toxicol; 2023 Sep; 37(9):e23391. PubMed ID: 37518988
[TBL] [Abstract][Full Text] [Related]
9. Upregulated bone morphogenetic protein 5 enhances proliferation and epithelial-mesenchymal transition process in benign prostatic hyperplasia via BMP/Smad signaling pathway.
Liu D; Liu J; Li Y; Liu H; Hassan HM; He W; Li M; Zhou Y; Fu X; Zhan J; Wang Z; Yang S; Chen P; Xu D; Wang X; DiSanto ME; Zeng G; Zhang X
Prostate; 2021 Dec; 81(16):1435-1449. PubMed ID: 34553788
[TBL] [Abstract][Full Text] [Related]
10. Evidence of TGF-β1 mediated epithelial-mesenchymal transition in immortalized benign prostatic hyperplasia cells.
Hu S; Yu W; Lv TJ; Chang CS; Li X; Jin J
Mol Membr Biol; 2014; 31(2-3):103-10. PubMed ID: 24650126
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor 10 (TLR10) exhibits suppressive effects on inflammation of prostate epithelial cells.
Fan Y; Yang L; Wei Q; Ding Y; Tang Z; Tan P; Lin T; Guo D; Qiu S
Asian J Androl; 2019; 21(4):393-399. PubMed ID: 30618413
[TBL] [Abstract][Full Text] [Related]
12. Aberrant Transforming Growth Factor-β Activation Recruits Mesenchymal Stem Cells During Prostatic Hyperplasia.
Wang L; Xie L; Tintani F; Xie H; Li C; Cui Z; Wan M; Zu X; Qi L; Cao X
Stem Cells Transl Med; 2017 Feb; 6(2):394-404. PubMed ID: 28191756
[TBL] [Abstract][Full Text] [Related]
13. Antagonists of growth hormone-releasing hormone inhibit proliferation induced by inflammation in prostatic epithelial cells.
Popovics P; Schally AV; Salgueiro L; Kovacs K; Rick FG
Proc Natl Acad Sci U S A; 2017 Feb; 114(6):1359-1364. PubMed ID: 28123062
[TBL] [Abstract][Full Text] [Related]
14. Potential ameliorative effects of epigallocatechin‑3‑gallate against testosterone-induced benign prostatic hyperplasia and fibrosis in rats.
Zhou J; Lei Y; Chen J; Zhou X
Int Immunopharmacol; 2018 Nov; 64():162-169. PubMed ID: 30179845
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor beta 1 and its receptor types I and II. Comparison in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma.
Royuela M; De Miguel MP; Bethencourt FR; Sanchez-Chapado M; Fraile B; Paniagua R
Growth Factors; 1998; 16(2):101-10. PubMed ID: 9932228
[TBL] [Abstract][Full Text] [Related]
16. Proteomic analysis of patient tissue reveals PSA protein in the stroma of benign prostatic hyperplasia.
O'Malley KJ; Eisermann K; Pascal LE; Parwani AV; Majima T; Graham L; Hrebinko K; Acquafondata M; Stewart NA; Nelson JB; Yoshimura N; Wang Z
Prostate; 2014 Jun; 74(8):892-900. PubMed ID: 24711254
[TBL] [Abstract][Full Text] [Related]
17. Epithelial-to-mesenchymal transition and estrogen receptor α mediated epithelial dedifferentiation mark the development of benign prostatic hyperplasia.
Shao R; Shi J; Liu H; Shi X; Du X; Klocker H; Lee C; Zhu Y; Zhang J
Prostate; 2014 Jun; 74(9):970-82. PubMed ID: 24752964
[TBL] [Abstract][Full Text] [Related]
18. Tight junction protein claudin-1 is downregulated by TGF-β1 via MEK signaling in benign prostatic epithelial cells.
Wang K; Pascal LE; Li F; Chen W; Dhir R; Balasubramani GK; DeFranco DB; Yoshimura N; He D; Wang Z
Prostate; 2020 Oct; 80(14):1203-1215. PubMed ID: 32692865
[TBL] [Abstract][Full Text] [Related]
19. METTL3 promotes prostatic hyperplasia by regulating PTEN expression in an m
Li J; Yao H; Huang J; Li C; Zhang Y; Xu R; Wang Z; Long Z; Tang J; Wang L
Cell Death Dis; 2022 Aug; 13(8):723. PubMed ID: 35985997
[TBL] [Abstract][Full Text] [Related]
20. IMPORTANCE OF APOPTOSIS MARKERS (MDM2, BCL-2 AND Bax) IN BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER.
Saker Z; Tsintsadze O; Jiqia I; Managadze L; Chkhotua A
Georgian Med News; 2015 Dec; (249):7-14. PubMed ID: 26719543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
